Lung fluid study for sepsis-related breathing problems
Part of Infections, Lungs & breathing clinical trials.
This study looks at the air sacs (alveoli) in your lungs to understand how they are affected by sepsis and a related condition called ARDS. By sampling the fluid in your lungs through a bronchoscopy, researchers hope to find new ways to treat and prevent lung damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with sepsis or septic shock.
- You need a breathing tube and machine (mechanical ventilation) within 72 hours of your sepsis diagnosis.
- You are not currently pregnant.
- You have not had a lung transplant, and you can safely have a bronchoscopy (a tube passed into your lungs for sampling).
- You (or your legal representative) can provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples from people in the ICU with sudden heart or lung problems caused by inflammation. The goal is to learn more about these conditions and improve future treatments.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study looks at two substances in saliva and lung fluid—called IL-6 and TNF-α—in children with severe lung failure (ARDS) who are on a breathing machine. Measuring these markers may help doctors better understand the condition and guide treatment.
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
This trial looks at a breathing measurement in people with severe sepsis or septic shock who are on a breathing machine in the ICU. The goal is to see whether this measurement can help predict which patients may develop organ failure, so care can be better timed.
This study looks at tiny particles from bacteria and a type of cell death called ferroptosis (iron-related cell breakdown) in patients who have sepsis from an infection outside the lungs. It aims to find signs that could lead to new treatments for lung injury caused by this bacteria.
Hear when a new Acute Hypoxemic Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.